Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo Barjesh Chander Sharma, Praveen Sharma, Amit Agrawal, Shiv Kumar Sarin Gastroenterology Volume 137, Issue 3, Pages 885-891.e1 (September 2009) DOI: 10.1053/j.gastro.2009.05.056 Copyright © 2009 AGA Institute Terms and Conditions
Figure 1 Probability of developing HE in patients receiving lactulose (dotted line) or placebo (continuous line). Figures in parentheses indicate the cumulative number of subjects who developed HE. Gastroenterology 2009 137, 885-891.e1DOI: (10.1053/j.gastro.2009.05.056) Copyright © 2009 AGA Institute Terms and Conditions
Supplementary Figure 1 Flow of participants in the study. Gastroenterology 2009 137, 885-891.e1DOI: (10.1053/j.gastro.2009.05.056) Copyright © 2009 AGA Institute Terms and Conditions